Third-generation oral contraceptives are an association of low-dose ethinyl estradiol and potent testosterone-derived progestins, developed in order to improve general and vascular tolerance.

Although the risk of acquiring PID at the time of insertion was not an issue for the woman presented in this case, historically she would not have been considered an appropriate candidate for an ...